REG - RELX PLC - Director/PDMR Shareholding

RelxAnnouncement

09/04/2020 14:10

RNS Number : 4138J
  
RELX PLC
  
09 April 2020
  
 

ISSUED ON BEHALF OF RELX PLC
Director/PDMR Shareholding 
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Henry Udow




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 


PDMR




b) 
 


Initial notification /Amendment 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name


RELX PLC




b) 
 


LEI 


549300WSX3VBUFFJOO66




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 


Ordinary Shares of 14 51/116p each ('Ordinary Shares')














Identification code 


ISIN: GB00B2B0DG97














b) 
 


Nature of the transaction 
 


Grant of option over Ordinary Shares under the RELX Group plc 2013 SAYE Share Option Scheme ("SAYE"). There is no price payable on grant or vesting of the option. The option price payable on exercise is £13.568. Subject to the rules of the SAYE, the option will become exercisable from 1 August 2023 for a period of six months.




c) 
 


Price(s) and volume(s) 




























Price(s)


Volume(s)
















Nil 


663






























d) 
 


Aggregated information 


















- Aggregated volume


663














- Price


Nil














e) 
 


Date of the transaction 
 


2020-04-08




f) 
 


Place of the transaction 
 
 


Outside of a trading venue






This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHFLFIVSTIAIII